New FAIR for AYA STAMP

Cancer Research UK: DETERMINE (Determining Extended Therapeutic indications for Existing drugs in Rare Molecularly defined Indications using a National Evaluation platform trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers with Actionable Genomic Alterations, including Common Cancers with Rare Actionable Alterations. More info here.

Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer

ECJ

Pearson, A. et al.

September 2023

Changing incentives to ACCELERATE drug development for paediatric cancer

Cancer Medicine

De Rojas, T. et al.

January 2023